Discontinuation report DILAUDID
| Report ID | 41479 |
| Drug Identification Number | 00786535 |
| Brand name | DILAUDID |
| Common or Proper name | hydromorphone hydrochloride |
| Company Name | PURDUE PHARMA |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | HYDROMORPHONE HYDROCHLORIDE |
| Strength(s) | 1MG |
| Dosage form(s) | |
| Route of administration | |
| Packaging size | 450ml |
| ATC code | |
| ATC description | |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2018-03-01 |
| Actual discontinuation date | 2018-03-01 |
| Remaining supply date | 2018-03-01 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2018-03-02 | English | Compare |
| v3 | 2018-03-01 | French | Compare |
| v2 | 2018-03-01 | English | Compare |
| v1 | 2018-03-01 | English | Compare |
Showing 1 to 4 of 4